申请人:NOVARTIS AG
公开号:US20170042925A1
公开(公告)日:2017-02-16
This invention relates to compounds represented by formula (I):
wherein the variables are defined as herein above, which are useful for treating diseases and conditions mediated by the sodium D-glucose co-transporter (SGLT), e.g. diabetes. The invention also provides methods of treating such diseases and conditions, and compositions etc. for their treatment.